Advisory Services Network, LLC Sarepta Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$67.31 - $124.76 $2,759 - $5,115	41 New	41 $3,000
Q1 2023 May 17, 2023	BUY	$117.53 - $155.99 $11,753 - $15,599	100 Added 243.9%	141 $19,000
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $4,135 - $5,417	41 New	41 $5,000
Q3 2021 Nov 05, 2021	SELL	$65.97 - $92.48 $9,301 - $13,039	-141 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$69.38 - $86.75 $9,782 - $12,231	141 New	141 $11,000
Q1 2021 May 24, 2021	SELL	$72.25 - $168.95 $10,187 - $23,821	-141 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$125.56 - $178.74 $14,313 - $20,376	-114 Reduced 44.71%	141 $24,000
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $32,415 - $43,946	255 New	255 $36,000
Q2 2020 Aug 10, 2020	SELL	$93.0 - $171.7 $38,037 - $70,225	-409 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $7,167 - $11,452	87 Added 27.02%	409 $40,000
Q4 2019 Feb 04, 2020	BUY	$76.53 - $135.58 $20,739 - $36,742	271 Added 531.37%	322 $42,000
Q2 2019 Aug 01, 2019	SELL	$112.21 - $151.95 $295,448 - $400,084	-2,633 Reduced 98.1%	51 $0
Q4 2018 Feb 15, 2019	SELL	$97.32 - $148.76 $15,473 - $23,652	-159 Reduced 5.59%	2,684 $293,000
Q3 2018 Nov 02, 2018	BUY	$115.31 - $161.51 $29,980 - $41,992	260 Added 10.07%	2,843 $459,000
Q2 2018 Jul 27, 2018	SELL	$71.74 - $153.69 $208,045 - $445,701	-2,900 Reduced 52.89%	2,583 $323,000
Q4 2017 Feb 08, 2018	BUY	$47.64 - $56.75 $261,210 - $311,160	5,483 New	5,483 $305,000
Q3 2017 Oct 12, 2017	SELL	$35.73 - $47.15 $8,932 - $11,787	-250 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	250	250 $8,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.